C12Y 503/04
Transposing s-s bonds
Official title: transposing S-S bonds (5.3.4)
C12Y503/04 (Transposing s-s bonds) appears on 64 US grants and 91 published applications in this corpus.
Search patents in C12Y- Granted patents
- 64
- Published applications
- 91
- Assignees
- 70
- Inventors
- 187
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 4 | 1 |
| 2003 | 2 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 2 | 1 |
| 2008 | 1 | 3 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 3 |
| 2014 | 1 | 1 |
| 2015 | 1 | 3 |
| 2016 | 6 | 6 |
| 2017 | 3 | 3 |
| 2018 | 6 | 4 |
| 2019 | 3 | 9 |
| 2020 | 6 | 10 |
| 2021 | 3 | 4 |
| 2022 | 4 | 3 |
| 2023 | 3 | 11 |
| 2024 | 5 | 6 |
| 2025 | 5 | 7 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Droplets and method for producing same1 Sep 2026US 12,723,240 B2Tohoku University
- Binder composition23 Dec 2025US 12,502,879 B2Rockwool A/S
- Construction of engineering bacteria for high expression of recombinant human serum albumin28 Oct 2025US 12,454,566 B2Shenzhen Protgen Ltd.
- E. coli strains having an oxidative cytoplasm9 Sep 2025US 12,410,393 B2Sutro Biopharma, Inc.
- Fire-protecting insulation product and use of such product26 Aug 2025US 12,397,537 B2Rockwool A/S
- Production of a negatively charged oligosaccharide by a cell24 Sep 2026US 2026/0286409 A1Inbiose N.V.
- Antiviral agent, pharmaceutical composition for treating or preventing viral infection, kit for evaluating risk of viral infection becoming severe, and method for evaluating risk of viral infection becoming severe27 Aug 2026US 2026/0248897 A1Tohoku University
- Expression of modified proteins in a peroxisome13 Aug 2026US 2026/0234647 A1The Regents of the University of California
- Production of proteins, including secreted proteins26 Mar 2026US 2026/0085107 A1Ginkgo Bioworks, Inc.
- E. coli strains having an oxidative cytoplasm19 Mar 2026US 2026/0078337 A1Sutro Biopharma, Inc.
Most cited
By later US patents
- Expression of heterologous proteins94US 6,361,969 B1Chiron Corporation · 2002
- Negative immunomodulation of immune responses by ERp518US 7,959,916 B2Fred Hutchinson Cancer Research Center · 2011
- Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination12US 10,023,847 B2Imnate Sarl · 2018
- Protein disulfide isomerase and method of using11US 5,874,247 ATakeda Chemical Industries, Ltd. · 1999
- Protein expression10US 9,206,454 B2Vtu Holding GmbH · 2015